Single‐chain Fvs
暂无分享,去创建一个
R. Raag | M. Whitlow | M Whitlow | R Raag
[1] I. Pastan,et al. A recombinant immunotoxin containing a disulfide-stabilized Fv fragment. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[2] P. Friedman,et al. Antitumor activity of the single-chain immunotoxin BR96 sFv-PE40 against established breast and lung tumor xenografts. , 1993, Journal of immunology.
[3] I. Pastan,et al. In vitro and in vivo activity of a recombinant toxin, OLX-209, which targets the erbB-2 oncoprotein. , 1994, Advances in enzyme regulation.
[4] K. D. Hardman,et al. An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability. , 1993, Protein engineering.
[5] R. Webster,et al. Recombinant anti-sialidase single-chain variable fragment antibody. Characterization, formation of dimer and higher-molecular-mass multimers and the solution of the crystal structure of the single-chain variable fragment/sialidase complex. , 1994, European journal of biochemistry.
[6] M. Whitlow,et al. Single-chain Fv proteins and their fusion proteins , 1991 .
[7] R. Lerner,et al. Antibody remodeling: a general solution to the design of a metal-coordination site in an antibody binding pocket. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[8] T. Holak,et al. Structural and dynamic properties of the Fv fragment and the single-chain Fv fragment of an antibody in solution investigated by heteronuclear three-dimensional NMR spectroscopy. , 1994, Biochemistry.
[9] T. Poulos,et al. The engineering of binding affinity at metal ion binding sites for the stabilization of proteins: subtilisin as a test case. , 1988, Biochemistry.
[10] S. Schuster,et al. Monoclonal antibodies specific for mercuric ions. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[11] J. Brisson,et al. Solution structure of a trisaccharide-antibody complex: comparison of NMR measurements with a crystal structure. , 1994, Biochemistry.
[12] T. Yokota,et al. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. , 1992, Cancer research.
[13] Y. Satow,et al. Phosphocholine binding immunoglobulin Fab McPC603. An X-ray diffraction study at 2.7 A. , 1985, Journal of molecular biology.
[14] T. Yokota,et al. Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms. , 1993, Cancer research.
[15] T. Holak,et al. Characterization of the linker peptide of the single‐chain Fv fragment of an antibody by NMR spectroscopy , 1993, FEBS letters.
[16] T. Yokota,et al. Differential metabolic patterns of iodinated versus radiometal chelated anticarcinoma single-chain Fv molecules. , 1992, Cancer research.
[17] R. Webster,et al. Recombinant antineuraminidase single chain antibody: Expression, characterization, and crystallization in complex with antigen , 1993, Proteins.
[18] M. Whitlow,et al. Multivalent Fvs: characterization of single-chain Fv oligomers and preparation of a bispecific Fv. , 1994, Protein engineering.
[19] R. Bruccoleri,et al. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[20] J. Huston,et al. Medical applications of single-chain antibodies. , 1993, International reviews of immunology.
[21] P. Bryan,et al. Large increases in general stability for subtilisin BPN' through incremental changes in the free energy of unfolding. , 1989, Biochemistry.
[22] A. Plückthun,et al. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. , 1988, Science.
[23] T. Bhat,et al. Crystallographic refinement of the three-dimensional structure of the FabD1.3-lysozyme complex at 2.5-A resolution. , 1991, The Journal of biological chemistry.
[24] E. Voss,et al. Construction, expression, and activity of a bivalent bispecific single-chain antibody. , 1994, The Journal of biological chemistry.
[25] I. Pastan,et al. A method for increasing the yield of properly folded recombinant fusion proteins: single-chain immunotoxins from renaturation of bacterial inclusion bodies. , 1992, Analytical biochemistry.
[26] L. Presta,et al. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling. , 1993, Journal of molecular biology.
[27] R. Glockshuber,et al. A comparison of strategies to stabilize immunoglobulin Fv-fragments. , 1990, Biochemistry.
[28] T Prospero,et al. "Diabodies": small bivalent and bispecific antibody fragments. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[29] S. Chen,et al. Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[30] K. D. Hardman,et al. Single-chain antigen-binding proteins. , 1988, Science.
[31] R. Raag,et al. Crystallization of single-chain Fv proteins. , 1993, Journal of molecular biology.
[32] R. Gibbs,et al. Construction and characterization of a single-chain catalytic antibody. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[33] Y. Li,et al. Structure of a single-chain antibody variable domain (Fv) fragment complexed with a carbohydrate antigen at 1.7-A resolution. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[34] A. Lawson,et al. Multimerization behaviour of single chain Fv variants for the tumour-binding antibody B72.3. , 1994, Protein engineering.
[35] G. Air,et al. Three-dimensional structures of influenza virus neuraminidase-antibody complexes. , 1989, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[36] R K Jain,et al. Barriers to drug delivery in solid tumors. , 1994, Scientific American.
[37] David I. Stuart,et al. Crystal structure at 2.8 Å resolution of a soluble form of the cell adhesion molecule CD2 , 1992, Nature.
[38] T. Teeri,et al. An active single-chain antibody containing a cellulase linker domain is secreted by Escherichia coli. , 1991, Protein engineering.
[39] R. Lerner,et al. Engineering metal coordination sites into the antibody light chain , 1993 .
[40] G. Winter,et al. Comparative stabilities in vitro and in vivo of a recombinant mouse antibody FvCys fragment and a bisFvCys conjugate. , 1992, Journal of immunology.
[41] E. Haber,et al. Protein engineering of single-chain Fv analogs and fusion proteins. , 1991, Methods in enzymology.
[42] P. Hudson,et al. Recombinant single-chain antibody peptide conjugates expressed in Escherichia coli for the rapid diagnosis of HIV. , 1994, Journal of immunological methods.
[43] K. D. Hardman,et al. Conformational stability, folding, and ligand-binding affinity of single-chain Fv immunoglobulin fragments expressed in Escherichia coli. , 1991, Biochemistry.